SCHEMBL2373407

SCHEMBL2373407

CC(C)COC(=O)N1CCc2c(Cl)cccc21

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 6/20 0.60
DRD2 P14416 2/20 0.47
DRD4 P21917 2/20 0.47
P2RX4 Q99571 1/20 0.45
HTR2C P28335 3/20 0.45
HTR2A P28223 2/20 0.45
AR P10275 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
AKT1 P31749 3/20 0.40
HTR2B P41595 2/20 0.40
SCN9A Q15858 1/20 0.40
SCN10A Q9Y5Y9 1/20 0.40
PIK3CD O00329 3/20 0.39
CYP3A4 P08684 3/20 0.39
PIK3CA P42336 3/20 0.39
PIK3CB P42338 3/20 0.39
PIK3CG P48736 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2373984 0.85 NOTUM (0.60) NOTUMDRD4P2RX4ARNPC1
SCHEMBL5568858 0.81 NOTUM (0.70) NOTUMDRD2DRD4HTR2CHTR2A
SCHEMBL2373892 0.80 NOTUM (0.45) NOTUMP2RX4HTR2CHTR2ANPC1
SCHEMBL2778816 0.79 NPC1 (0.64) NOTUMP2RX4NPC1RAB9AL3MBTL1
SCHEMBL868725 0.77 NOTUM (0.65) NOTUMDRD2DRD4HTR2CHTR2A
SCHEMBL5765327 0.76 NOTUM (1.00) NOTUMDRD2DRD4HTR2CHTR2A
SCHEMBL5766165 0.76 NOTUM (1.00) NOTUMDRD2DRD4HTR2CHTR2A
SCHEMBL2373630 0.75 GPR119 (0.43) NOTUMP2RX4NPC1RAB9AL3MBTL1
SCHEMBL2375244 0.74 NOTUM (0.73) NOTUMDRD2DRD4HTR2CHTR2A
SCHEMBL5565636 0.72 NOTUM (0.68) NOTUMDRD2DRD4NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2549868-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2013-01-30 EP disclosed
WO-2011119663-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-09-29 WO disclosed